Identifier
Created
Classification
Origin
03ABUDHABI2380
2003-05-18 09:28:00
UNCLASSIFIED
Embassy Abu Dhabi
Cable title:
EXTRANCHECK: POST-SHIPMENT VERIFICATION: GULF
how-tonull Diana T Fritz 05/24/2007 04:13:41 PM From DB/Inbox: Search Results Cable Text: UNCLASSIFIED SIPDIS TELEGRAM May 18, 2003 To: No Action Addressee Action: Unknown From: AMEMBASSY ABU DHABI (ABU DHABI 2380 - ROUTINE) TAGS: ETTC Captions: None Subject: EXTRANCHECK: POST-SHIPMENT VERIFICATION: GULF PHARMACEUTICAL INDUSTRIES Ref: None _________________________________________________________________ UNCLAS ABU DHABI 02380 SIPDIS CXABU: INFO: ECON AMB DCM Laser1: ACTION: FCS DISSEMINATION: FCS CHARGE: FCS APPROVED: A/DCM:TEWILLIAMS DRAFTED: FCS: MARY O'BRIEN CLEARED: FCS: JLANCIA VZCZCADI777 RR RUCPDOC RUEHC RUEHRO RUEHDI DE RUEHAD #2380 1380928 ZNR UUUUU ZZH R 180928Z MAY 03 FM AMEMBASSY ABU DHABI TO RUCPDOC/USDOC WASHDC INFO RUEHC/SECSTATE WASHDC 9980 RUEHRO/AMEMBASSY ROME 0678 RUEHDI/AMCONSUL DUBAI 3132
UNCLAS ABU DHABI 002380
SIPDIS
USDOC FOR 532/OEA/M.CORSEY/DAVID SEVERSON
ROME FOR CUSTOMS ATTACH
STATE FOR NEA/ARP - MALENAS
DUBAI FOR CG AND FCS
E.O. 12958: N/A
TAGS: ETTC TC
SUBJECT: EXTRANCHECK: POST-SHIPMENT VERIFICATION: GULF
PHARMACEUTICAL INDUSTRIES
REF: USDOC 1648
UNCLAS ABU DHABI 002380
SIPDIS
USDOC FOR 532/OEA/M.CORSEY/DAVID SEVERSON
ROME FOR CUSTOMS ATTACH
STATE FOR NEA/ARP - MALENAS
DUBAI FOR CG AND FCS
E.O. 12958: N/A
TAGS: ETTC TC
SUBJECT: EXTRANCHECK: POST-SHIPMENT VERIFICATION: GULF
PHARMACEUTICAL INDUSTRIES
REF: USDOC 1648
1. REFTEL REQUESTED POST CONDUCT A POST-SHIPMENT VERIFICATION
FOR A TAYLOR WHARTON CRYOSTORAGE SYSTEM WITH GULF PHARMACEUTICAL
INDUSTRIES.
2. GULF PHARMACEUTICAL INDUSTRIES, ALSO KNOWN HERE AS JULPHAR,
IS WELL-KNOWN TO BOTH THE EMBASSY AND CONSULATE IN THE UAE. IT
HAS ITS OWN WEBSITE AT WWW. JULPHAR.COM. THE CHAIRMAN OF JULPHAR
IS SHEIKH SAUD BIN SAQR AL-QASSIMI, A MEMBER OF THE RULING FAMILY
OF RAS AL-KHAIMAH. THE COMPANY WAS FOUNDED IN THE LATE 1960S AND
IS THE LARGEST PHARMACEUTICAL COMPANY IN THE GULF REGION. THE
COMPANY HAS SIX MANUFACTURING DIVISIONS, FOUR IN THE DIGDAGA AREA
OF RAS AL KHAIMAH AND ONE EACH IN ECUADOR AND GERMANY. THERE ARE
APPROXIMATELY 1000 EMPLOYEES IN RAS AL KHAIMAH. 95%OF ALL THE
PRODUCTION AT THE RAS AL KHAIMAH FACILITY IS FOR EXPORT FROM THE
UAE TO OVER 38 COUNTRIES AROUND THE WORLD.
3. THE RAS AL KHAIMAH FACILITY IS VERY LARGE AND ACCESS TO IT
IS STRICTLY CONTROLLED. ALL VISITORS ARE REQUIRED TO OBTAIN A
VISITOR'S ID BADGE AND WRITTEN GATE PASS IN THE PASS OFFICE AFTER
HAVING PRESENTED THE PROPER IDENTIFICATION DOCUMENTS, WHICH ARE
HELD UNTIL THE PERSON EXITS THE FACILITY. THE FACILITY HAS ITS
OWN WATER TREATMENT FACILITY AND UTILITY SUBSTATION.
4. ON MAY 14, 2003, COMMERCIAL OFFICER MARY O'BRIEN MET WITH
DR. SAID IBRAHIM, DIRECTOR OF MANUFACTURING (SEE THE WEBSITE FOR
HIS PHOTO) REGARDING THE TAYLOR WHARTON CRYOSTORAGE SYSTEM. DR.
IBRAHIM HAS BEEN WITH JULPHAR SINCE LEAVING EGYPT IN 1998 TO
ACCEPT THE POSITION AT JULPHAR. HE HAS 35 YEARS OF EXPERIENCE IN
THE PHARMACEUTICAL INDUSTRY. UPON ENTERING THE JULPHAR II
BUILDING COMMOFF HAD TO CHANGE INTO A WHITE LABCOAT, HAIR
COVERING (FOR NONCONTAMINATION PURPOSES) AND SHOE COVERINGS.
5. DR. IBRAHIM EXPLAINED TO COMOFF THAT JULPHAR WAS IN THE
PROCESS OF CONSTRUCTING A BIOTECHNOLOGY LABORATORY IN ANOTHER
PART OF THE JULPHAR II BUILDING. DR. IBRAHIM HAD THE CONSTRUCTION
PLANS FOR THE BIOTECH LAB ON HIS DESK. THIS BIOTECH LAB WOULD BE
USED TO PRODUCE ERYTHROPOEITIN, ALSO KNOWN AS PROCRIT IN THE US
(MARKETED IN EUROPE AS EPOTIN). THIS DRUG, USED TO TREAT SEVERE
ANEMIA IN CANCER PATIENTS AND HIV-AZT PATIENTS, IS A NATURAL
HORMONE. THE PRODUCTION PROCESS REQUIRES THE USE OF MAMMALIAN
CELL CULTURES, WHICH MUST BE KEPT FROZEN UNTIL USE. THE TAYLOR-
WHARTON CRYOSTORAGE MODEL 24K UNIT WILL BE USED FOR THESE
MAMMALIAN CELL CULTURES. DR. IBRAHIM SAID THEY EXPECT TO HAVE
THE BIOTECH LAB COMPLETED IN 3 TO 4 MONTHS AND ALSO SAID COMMOFF
WAS WELCOME TO COME BACK WHEN THE LAB IS COMPLETED AND SEE THAT
THE CRYOSTORAGE UNIT IS IN USE THERE.
6. DR IBRAHIM THEN TOOK COMMOFF TO THE STORAGE SECTION OF
JULPHAR II WHERE THE CRYOSTORAGE UNIT IS CURRENTLY BEING KEPT
PENDING COMPLETION OF THE BIOTECH LAB. THE UNIT IS APPROXIMATELY
3X3X3 AND IS VERY HEAVY. THE SERIAL NUMBER OF THE UNIT IS 555-
010-V1. DR. IBRAHIM CONFIRMED THAT THE UNIT WAS BOUGHT FROM
BEVCO RATHER THAN TAYLOR-WHARTON IN ORDER TO SAVE MONEY. HE SAID
IT WAS SHIPPED BY AIR BUT HE DID NOT HAVE THE AIR WAYBILL OR
OTHER EXPORT DOCUMENTS.
7. DR. IBRAHIM SHOWED COMMOFF A COPY OF THE INVOICE FROM TAYLOR
WHARTON TO BEVCO, 651 WEST 600 SOUTH, SALT LAKE CITY, UTAH. THE
INVOICE WAS STAMPED BY THE TEXAS CHAMBER OF COMMERCE CERTIFYING
IT TO BE OF U.S. ORIGIN.
8. ALSO ATTACHED IS WHAT APPEARS TO BE AN INLAND BILL OF LADING
FROM EXEL OF DALLAS, TEXAS. ON THIS DOCUMENT THE SHIPPER IS
LISTED AS KEVIN PETERSON OF INSIGHT EXHIBITS, 1367 SOUTH 700
WEST, SALT LAKE CITY. THIS IS A COMPANY SPECIALIZING IN CREATING
EXHIBITION BOOTHS FOR COMPANIES TO USE AT TRADE SHOWS (WWW.
INSIGHTEXHIBITS.COM).
9. THE THIRD-PARTY BILLING ADDRESS IS LISTED AS DANA COONS,
CHURCH OF LATTER DAY SAINTS, 50 EAST NORTH TEMPLE, SALT LAKE CITY
(THE SALT LAKE CITY TEMPLE OF THE CHURCH OF LDS).
10. AS REQUESTED IN REFTEL, THE INTENDED END-USER IS GULF
PHARMACEUTICALS AND THE INTENDED END USE IS FOR THE STORAGE OF
MAMMALIAN CELL CULTURES FOR USE IN THE PRODUCTION OF
ERYTHROPOEITIN. PLEASE ADVISE IF ANY ADDITIONAL INFORMATION IS
REQUIRED.
ALBRIGHT
SIPDIS
USDOC FOR 532/OEA/M.CORSEY/DAVID SEVERSON
ROME FOR CUSTOMS ATTACH
STATE FOR NEA/ARP - MALENAS
DUBAI FOR CG AND FCS
E.O. 12958: N/A
TAGS: ETTC TC
SUBJECT: EXTRANCHECK: POST-SHIPMENT VERIFICATION: GULF
PHARMACEUTICAL INDUSTRIES
REF: USDOC 1648
1. REFTEL REQUESTED POST CONDUCT A POST-SHIPMENT VERIFICATION
FOR A TAYLOR WHARTON CRYOSTORAGE SYSTEM WITH GULF PHARMACEUTICAL
INDUSTRIES.
2. GULF PHARMACEUTICAL INDUSTRIES, ALSO KNOWN HERE AS JULPHAR,
IS WELL-KNOWN TO BOTH THE EMBASSY AND CONSULATE IN THE UAE. IT
HAS ITS OWN WEBSITE AT WWW. JULPHAR.COM. THE CHAIRMAN OF JULPHAR
IS SHEIKH SAUD BIN SAQR AL-QASSIMI, A MEMBER OF THE RULING FAMILY
OF RAS AL-KHAIMAH. THE COMPANY WAS FOUNDED IN THE LATE 1960S AND
IS THE LARGEST PHARMACEUTICAL COMPANY IN THE GULF REGION. THE
COMPANY HAS SIX MANUFACTURING DIVISIONS, FOUR IN THE DIGDAGA AREA
OF RAS AL KHAIMAH AND ONE EACH IN ECUADOR AND GERMANY. THERE ARE
APPROXIMATELY 1000 EMPLOYEES IN RAS AL KHAIMAH. 95%OF ALL THE
PRODUCTION AT THE RAS AL KHAIMAH FACILITY IS FOR EXPORT FROM THE
UAE TO OVER 38 COUNTRIES AROUND THE WORLD.
3. THE RAS AL KHAIMAH FACILITY IS VERY LARGE AND ACCESS TO IT
IS STRICTLY CONTROLLED. ALL VISITORS ARE REQUIRED TO OBTAIN A
VISITOR'S ID BADGE AND WRITTEN GATE PASS IN THE PASS OFFICE AFTER
HAVING PRESENTED THE PROPER IDENTIFICATION DOCUMENTS, WHICH ARE
HELD UNTIL THE PERSON EXITS THE FACILITY. THE FACILITY HAS ITS
OWN WATER TREATMENT FACILITY AND UTILITY SUBSTATION.
4. ON MAY 14, 2003, COMMERCIAL OFFICER MARY O'BRIEN MET WITH
DR. SAID IBRAHIM, DIRECTOR OF MANUFACTURING (SEE THE WEBSITE FOR
HIS PHOTO) REGARDING THE TAYLOR WHARTON CRYOSTORAGE SYSTEM. DR.
IBRAHIM HAS BEEN WITH JULPHAR SINCE LEAVING EGYPT IN 1998 TO
ACCEPT THE POSITION AT JULPHAR. HE HAS 35 YEARS OF EXPERIENCE IN
THE PHARMACEUTICAL INDUSTRY. UPON ENTERING THE JULPHAR II
BUILDING COMMOFF HAD TO CHANGE INTO A WHITE LABCOAT, HAIR
COVERING (FOR NONCONTAMINATION PURPOSES) AND SHOE COVERINGS.
5. DR. IBRAHIM EXPLAINED TO COMOFF THAT JULPHAR WAS IN THE
PROCESS OF CONSTRUCTING A BIOTECHNOLOGY LABORATORY IN ANOTHER
PART OF THE JULPHAR II BUILDING. DR. IBRAHIM HAD THE CONSTRUCTION
PLANS FOR THE BIOTECH LAB ON HIS DESK. THIS BIOTECH LAB WOULD BE
USED TO PRODUCE ERYTHROPOEITIN, ALSO KNOWN AS PROCRIT IN THE US
(MARKETED IN EUROPE AS EPOTIN). THIS DRUG, USED TO TREAT SEVERE
ANEMIA IN CANCER PATIENTS AND HIV-AZT PATIENTS, IS A NATURAL
HORMONE. THE PRODUCTION PROCESS REQUIRES THE USE OF MAMMALIAN
CELL CULTURES, WHICH MUST BE KEPT FROZEN UNTIL USE. THE TAYLOR-
WHARTON CRYOSTORAGE MODEL 24K UNIT WILL BE USED FOR THESE
MAMMALIAN CELL CULTURES. DR. IBRAHIM SAID THEY EXPECT TO HAVE
THE BIOTECH LAB COMPLETED IN 3 TO 4 MONTHS AND ALSO SAID COMMOFF
WAS WELCOME TO COME BACK WHEN THE LAB IS COMPLETED AND SEE THAT
THE CRYOSTORAGE UNIT IS IN USE THERE.
6. DR IBRAHIM THEN TOOK COMMOFF TO THE STORAGE SECTION OF
JULPHAR II WHERE THE CRYOSTORAGE UNIT IS CURRENTLY BEING KEPT
PENDING COMPLETION OF THE BIOTECH LAB. THE UNIT IS APPROXIMATELY
3X3X3 AND IS VERY HEAVY. THE SERIAL NUMBER OF THE UNIT IS 555-
010-V1. DR. IBRAHIM CONFIRMED THAT THE UNIT WAS BOUGHT FROM
BEVCO RATHER THAN TAYLOR-WHARTON IN ORDER TO SAVE MONEY. HE SAID
IT WAS SHIPPED BY AIR BUT HE DID NOT HAVE THE AIR WAYBILL OR
OTHER EXPORT DOCUMENTS.
7. DR. IBRAHIM SHOWED COMMOFF A COPY OF THE INVOICE FROM TAYLOR
WHARTON TO BEVCO, 651 WEST 600 SOUTH, SALT LAKE CITY, UTAH. THE
INVOICE WAS STAMPED BY THE TEXAS CHAMBER OF COMMERCE CERTIFYING
IT TO BE OF U.S. ORIGIN.
8. ALSO ATTACHED IS WHAT APPEARS TO BE AN INLAND BILL OF LADING
FROM EXEL OF DALLAS, TEXAS. ON THIS DOCUMENT THE SHIPPER IS
LISTED AS KEVIN PETERSON OF INSIGHT EXHIBITS, 1367 SOUTH 700
WEST, SALT LAKE CITY. THIS IS A COMPANY SPECIALIZING IN CREATING
EXHIBITION BOOTHS FOR COMPANIES TO USE AT TRADE SHOWS (WWW.
INSIGHTEXHIBITS.COM).
9. THE THIRD-PARTY BILLING ADDRESS IS LISTED AS DANA COONS,
CHURCH OF LATTER DAY SAINTS, 50 EAST NORTH TEMPLE, SALT LAKE CITY
(THE SALT LAKE CITY TEMPLE OF THE CHURCH OF LDS).
10. AS REQUESTED IN REFTEL, THE INTENDED END-USER IS GULF
PHARMACEUTICALS AND THE INTENDED END USE IS FOR THE STORAGE OF
MAMMALIAN CELL CULTURES FOR USE IN THE PRODUCTION OF
ERYTHROPOEITIN. PLEASE ADVISE IF ANY ADDITIONAL INFORMATION IS
REQUIRED.
ALBRIGHT